Send feedback

DBT p.Ala327Thr

c.979G>A · rs754125552 · VCV2151227

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.234 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00446%, eas)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
maple syrup urine disease

Computational evidence

Protein change
AlphaMissense0.234likely benign
REVEL0.33indeterminate
SaProtLLR -11.33damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.5GERP 0.12, phastCons 1
Regional constrainto/e 0.88unconstrained · MANE · 54 kb · p 0.0036 · regional, not allelic
Overall
CADD22.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00446% East Asian · 2/44,810 alleles
Filtering AF 0.00299% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00267%
Overall 0.0037% 54/1,461,208 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.008% 12,495
East Asiangrpmax 0.00446% 22,405
European (non-Finnish) 0.0039% 25,641
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,594

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DBT
Protein
p.Ala327Thr
Coding
c.979G>A
MANE Select
NM_001918
dbSNP
rs754125552
Type
single nucleotide variant
Location
chr1:100210732 (GRCh38)
Gene constraint
LOEUF 1.255 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 78.71 · 5 PDB
Full DBT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

maple syrup urine disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Maple syrup urine disease (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dbt-p-ala327thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown